Patients with Type 2 Diabetes and Residual Insulin Secretory Capacity Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring
Author:
Affiliation:
1. Dexcom, Inc., San Diego, CA, USA
2. Jaeb Center for Health Research, Tampa, FL, USA
Funder
Dexcom
Publisher
SAGE Publications
Subject
Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/19322968211007880
Reference3 articles.
1. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections
2. C-peptide concentrations in patients with type 2 diabetes treated with insulin
3. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An in-silico modeling approach to separate exogenous and endogenous plasma insulin appearance, with application to inhaled insulin;Scientific Reports;2024-05-13
2. With or without residual C-peptide, patients with type 2 diabetes realize glycemic benefits from real-time continuous glucose monitoring;Diabetes Technology & Therapeutics;2021-10-27
3. Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?;Diabetes Technology & Therapeutics;2021-10-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3